Search Results - "Bhattacharyya, Pritish"
-
1
An Immunohistochemical Survey of SNARE Proteins Shows Distinct Patterns of Expression in Hematolymphoid Neoplasia
Published in American journal of clinical pathology (01-05-2016)“…Objectives: Five proteins from the soluble N-ethylmaleimide–sensitive factor activating protein receptor (SNARE) complex family were studied in normal…”
Get full text
Journal Article -
2
STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer
Published in Clinical cancer research (01-09-2018)“…Most bladder cancers are early-stage tumors known as papillary non-muscle-invasive bladder cancer (NMIBC). After resection, up to 70% of NMIBCs recur locally,…”
Get full text
Journal Article -
3
Reduced‐dose fludarabine, cyclophosphamide, and rituximab (FCR‐Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia
Published in American journal of hematology (01-06-2015)“…Fludarabine, cyclophosphamide, and rituximab (FCR) remains the standard of care for fit chronic lymphocytic leukemia (CLL) patients requiring first therapy…”
Get full text
Journal Article -
4
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first‐relapse/primary refractory diffuse large B‐cell lymphoma
Published in British journal of haematology (01-07-2014)“…Summary Relapsed/refractory diffuse large B‐cell lymphoma (DLBCL) is associated with a poor prognosis. Outcomes are particularly poor following…”
Get full text
Journal Article -
5
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
Published in Indian journal of pathology & microbiology (01-07-2013)“…Chronic lymphocytic leukemia (CLL) is the most common leukemia of adults in the western world and constitutes about 33% of all leukemia's. The incidence of CLL…”
Get full text
Journal Article -
6
γ-Synuclein Is a Promising New Marker for Staining Reactive Follicular Dendritic Cells, Follicular Dendritic Cell Sarcoma, Kaposi Sarcoma, and Benign and Malignant Vascular Tumors
Published in The American journal of surgical pathology (01-12-2011)“…Synucleins are small soluble proteins found in normal brain that facilitate rapid release of neurotransmitters. α-synuclein is a major component of the Lewy…”
Get full text
Journal Article -
7
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial
Published in EJHaem (01-08-2021)“…Multiple myeloma (MM) is a heterogeneous hematologic malignancy associated with several risk factors including genetic aberrations which impact disease…”
Get full text
Journal Article -
8
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
Published in Journal of hematology and oncology (29-08-2013)“…High risk, unfavorable classical Hodgkin lymphoma (cHL) includes those patients with primary refractory or early relapse, and progressive disease. To improve…”
Get full text
Journal Article -
9
T-cell prolymphocytic leukemia with extensive cardiovascular infiltrate leading to multiple myocardial infarctions and cardiac death
Published in Texas Heart Institute journal (01-12-2014)“…Lymphocytic neoplasm involving the heart is not common and usually presents with pericardial effusion or focal myocardial infiltration. Myocardial infarctions…”
Get full text
Journal Article -
10
Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature
Published in Acta haematologica (01-01-2010)“…Kaposi sarcoma-associated herpesvirus (KSHV), or human herpesvirus type 8 (HHV8), is consistently identified in 2 human immunodeficiency virus (HIV)-associated…”
Get more information
Journal Article -
11
Spectrin isoforms: differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disorders
Published in American journal of clinical pathology (01-08-2011)“…Spectrins are large, rod-like, multifunctional molecules that participate in maintaining cell structure, signal transmission, and DNA repair. Because little is…”
Get full text
Journal Article -
12
AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles
Published in Modern pathology (01-03-2006)“…Based on gene expression profiling, diffuse large B-cell lymphomas arising in immunocompetent patients can be divided into germinal center and activated B-cell…”
Get full text
Journal Article -
13
Germinal center and activated B-cell profiles separate burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases
Published in American journal of clinical pathology (01-11-2005)“…Morphologic features of Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) overlap. No single phenotypic marker or molecular abnormality is…”
Get full text
Journal Article -
14
A unique case of merkel cell carcinoma and chronic lymphocytic leukaemia presenting in a single cutaneous lesion (collision tumour)
Published in BMJ case reports (2009)“…A 58-year-old man with 10 year history of chronic lymphocytic leukaemia (CLL) presented with a bulging mass (3.2×1.6×1.5 cm) in the right anterior abdominal…”
Get full text
Journal Article -
15
Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)
Published in Blood (15-11-2022)Get full text
Journal Article -
16
Abstract 1558: STAG2 as a biomarker for prediction of recurrence in papillary non-muscle invasive bladder cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Purpose: Bladder cancer is the sixth most common human cancer. Most cases are early-stage tumors known as papillary non-muscle invasive bladder cancer…”
Get full text
Journal Article -
17
-
18
Treatment of High Risk DLBCL with DA-R-EPOCH in Those Unable to Tolerate Intensive Chemotherapy: Well-Tolerated and Effective, but Inadequate in Double/Triple Hit or Expressing DLBCL
Published in Blood (08-12-2017)“…Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) with a heterogeneous clinical course and mutational…”
Get full text
Journal Article -
19
Phase Ib-II Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell Lymphoma
Published in Blood (08-12-2017)“…Introduction: In spite of improvement seen in frontline therapies in MCL, a majority of pts still relapse and have then short remissions while developing…”
Get full text
Journal Article -
20
Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine
Published in Oncotarget (11-10-2016)“…Hodgkin lymphoma (HL) is a lymphoid malignancy that is typically derived from germinal-center B cells. EBV infection, mutations in NF-κB pathway genes, and…”
Get full text
Journal Article